Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Enterprise Value (2016 - 2025)

Conmed (CNMD) has disclosed Enterprise Value for 16 consecutive years, with -$40.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 66.88% year-over-year to -$40.8 million, compared with a TTM value of -$40.8 million through Dec 2025, down 66.88%, and an annual FY2025 reading of -$40.8 million, down 66.88% over the prior year.
  • Enterprise Value was -$40.8 million for Q4 2025 at Conmed, down from -$38.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$20.8 million in Q4 2021 and bottomed at -$53.2 million in Q2 2022.
  • Average Enterprise Value over 5 years is -$33.0 million, with a median of -$32.4 million recorded in 2021.
  • The sharpest move saw Enterprise Value skyrocketed 47.61% in 2023, then plummeted 66.88% in 2025.
  • Year by year, Enterprise Value stood at -$20.8 million in 2021, then tumbled by 38.83% to -$28.9 million in 2022, then rose by 16.05% to -$24.3 million in 2023, then dropped by 0.67% to -$24.5 million in 2024, then tumbled by 66.88% to -$40.8 million in 2025.
  • Business Quant data shows Enterprise Value for CNMD at -$40.8 million in Q4 2025, -$38.9 million in Q3 2025, and -$33.9 million in Q2 2025.